Thomas Valerius
Arzt,
Hochschullehrer
Hat mitgewirkt an:
-
Corrigendum : Targeting myeloid checkpoint molecules in combination with antibody therapy: A novel anti-cancer strategy with IgA antibodies?
-
Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9
-
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria
-
Organ-on-a-chip models for development of cancer immunotherapies